Stockreport

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Generation Bio Co. - Common stock  (GBIO) 
PDF - Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - D [Read more]